tranexamic acid has been researched along with Anemia in 58 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Anemia: A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The primary study objective is to determine the effect of perioperative treatment with either intravenous iron, tranexamic acid or with a combination of both medicines on the reduction of intraoperative and postoperative red blood cell transfusions in gynaecological carcinoma patients." | 9.51 | Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial. ( Amstad, G; Geiger, J; Heinzelmann, V; Montavon, C; Werlen, L, 2022) |
| "Our aim was to compare the therapeutic efficacies of norethisterone acid (NETA), tranexamic acid and levonorgestrel-releasing intrauterine system (LNG-IUS) in treating idiopathic heavy menstrual bleeding (HMB)." | 9.22 | Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study. ( Evliyaoglu, O; Haberal, A; Kayikcioglu, F; Kiseli, M, 2016) |
| " The primary study objective is to determine the effect of perioperative treatment with either intravenous iron, tranexamic acid or with a combination of both medicines on the reduction of intraoperative and postoperative red blood cell transfusions in gynaecological carcinoma patients." | 5.51 | Perioperative management with ferric carboxymaltose and tranexamic acid to reduce transfusion rate in gynaecological carcinoma surgery (TRANAFER-Study): study protocol for a single-blind, monocentre, randomised trial. ( Amstad, G; Geiger, J; Heinzelmann, V; Montavon, C; Werlen, L, 2022) |
| "Our aim was to compare the therapeutic efficacies of norethisterone acid (NETA), tranexamic acid and levonorgestrel-releasing intrauterine system (LNG-IUS) in treating idiopathic heavy menstrual bleeding (HMB)." | 5.22 | Comparison of Therapeutic Efficacies of Norethisterone, Tranexamic Acid and Levonorgestrel-Releasing Intrauterine System for the Treatment of Heavy Menstrual Bleeding: A Randomized Controlled Study. ( Evliyaoglu, O; Haberal, A; Kayikcioglu, F; Kiseli, M, 2016) |
| " Two multivariable logistic regression models, for postoperative anemia (hemoglobin < 10 g/dL) and allogeneic blood transfusion included 8 variables: age, sex, body mass index, preoperative hemoglobin level, tranexamic acid total dose, American Society of Anesthesiologists level, operative time, and drain use." | 4.31 | Predicting Postoperative Anemia and Blood Transfusion Following Total Knee Arthroplasty. ( Ast, MP; Chalmers, BP; Della Valle, AG; Kolin, DA; Landy, DC; Lyman, S, 2023) |
| "Tranexamic acid is significantly less expensive than FE or EPO as a treatment option for total joint arthroplasty patients presenting with preoperative anemia." | 3.83 | Cost Analysis of Tranexamic Acid in Anemic Total Joint Arthroplasty Patients. ( Ani, F; Phan, DL; Schwarzkopf, R, 2016) |
| " Our aim was to assess whether the introduction of a pre-, intra-, and postoperative PBM protocol combining erythropoietin (EPO), ferric carboxymaltose (FCM), and tranexamic acid was effective in reducing perioperative transfusion and postoperative anemia." | 3.83 | Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study. ( Bizot, P; Chassier, C; Chaudet, A; Lasocki, S; Rineau, E, 2016) |
| "Tranexamic acid (TXA) has been considered effective in preventing anemia in total hip arthroplasty, but its role in hemiarthroplasty is debated." | 3.01 | Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis. ( Augustinus, S; Gardenbroek, TJ; Goslings, JC; Mulders, MAM, 2023) |
| "Tranexamic acid was given intravenously or topically during the perioperative period." | 3.01 | Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews. ( Estcourt, LJ; Griffin, XL; Lewis, SR; Pritchard, MW; Stanworth, SJ, 2023) |
| "Tranexamic acid (TXA) has been investigated further in patients with hip surgery and shows reduction of bleeding." | 2.82 | Patient blood management and patient safety. ( Steinbicker, AU; Zacharowski, K; Zoller, H, 2022) |
| "Tranexamic acid is an antifibrinolytic agent that has been widely used in other surgical specialties, especially in cardiac, orthopedic, and trauma surgery." | 2.58 | The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations. ( Cho, MJ; Rohrich, RJ, 2018) |
| "Fibrin sealant also has this potential, but is not more potent than tranexamic acid." | 2.52 | Prevention of post-operative anaemia in hip and knee arthroplasty--a systematic review. ( Husted, H; Khan, N; Troelsen, A, 2015) |
| "Future treatment of trauma-induced coagulopathy may be based on systemic antifibrinolytics, local haemostatics and individualized point-of-care-guided rational use of coagulation factor concentrates such as fibrinogen, prothrombin complex concentrate, recombinant factor VIIa and factor XIII." | 2.48 | Emerging treatment strategies for trauma-induced coagulopathy. ( Fries, D; Sorensen, B, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (3.45) | 29.6817 |
| 2010's | 38 (65.52) | 24.3611 |
| 2020's | 18 (31.03) | 2.80 |
| Authors | Studies |
|---|---|
| Brenner, A | 1 |
| Roberts, I | 4 |
| Balogun, E | 3 |
| Bello, FA | 1 |
| Chaudhri, R | 3 |
| Fleming, C | 1 |
| Javaid, K | 2 |
| Kayani, A | 2 |
| Lubeya, MK | 1 |
| Mansukhani, R | 1 |
| Olayemi, O | 1 |
| Prowse, D | 2 |
| Vwalika, B | 2 |
| Shakur-Still, H | 3 |
| Amstad, G | 1 |
| Geiger, J | 1 |
| Werlen, L | 1 |
| Montavon, C | 1 |
| Heinzelmann, V | 1 |
| Zacharowski, K | 1 |
| Zoller, H | 1 |
| Steinbicker, AU | 1 |
| Augustinus, S | 2 |
| Mulders, MAM | 2 |
| Gardenbroek, TJ | 2 |
| Goslings, JC | 2 |
| Kolin, DA | 2 |
| Lyman, S | 1 |
| Della Valle, AG | 1 |
| Ast, MP | 2 |
| Landy, DC | 1 |
| Chalmers, BP | 2 |
| Lewis, SR | 1 |
| Pritchard, MW | 1 |
| Estcourt, LJ | 1 |
| Stanworth, SJ | 1 |
| Griffin, XL | 1 |
| Jung, HJ | 1 |
| Kang, MW | 1 |
| Lee, JH | 1 |
| Lee, JK | 1 |
| Kim, JI | 1 |
| Lasocki, S | 3 |
| Capdevila, X | 2 |
| Vielle, B | 2 |
| Bijok, B | 1 |
| Lahlou-Casulli, M | 2 |
| Collange, V | 2 |
| Grillot, N | 1 |
| Danguy des Deserts, M | 2 |
| Duchalais, A | 2 |
| Delannoy, B | 1 |
| Drugeon, B | 2 |
| Bouzat, P | 2 |
| David, JS | 2 |
| Rony, L | 1 |
| Loupec, T | 2 |
| Léger, M | 2 |
| Rineau, E | 3 |
| Sculco, PK | 1 |
| Gonzalez Della Valle, A | 1 |
| Rodriguez, JA | 1 |
| Hourlier, H | 1 |
| Fennema, P | 1 |
| Zhao, M | 1 |
| Geng, X | 1 |
| Wang, C | 1 |
| Zeng, L | 1 |
| Tian, H | 1 |
| Lloyd, TD | 1 |
| Neal-Smith, G | 1 |
| Fennelly, J | 1 |
| Claireaux, H | 1 |
| Bretherton, C | 1 |
| Carr, AJ | 1 |
| Murphy, M | 1 |
| Kendrick, BJ | 1 |
| Palmer, AJR | 1 |
| Picetti, R | 1 |
| Miller, L | 1 |
| Pepple, T | 2 |
| Beaumont, D | 2 |
| Asonganyi, E | 1 |
| El-Sheikh, M | 1 |
| Arulkumaran, S | 2 |
| Biboulet, P | 1 |
| Motais, C | 1 |
| Pencole, M | 1 |
| Karam, O | 1 |
| Dangelser, G | 1 |
| Smilevitch, P | 1 |
| Maissiat, G | 1 |
| Bringuier, S | 1 |
| Scrimshire, AB | 2 |
| Fairhurst, C | 2 |
| McDaid, C | 2 |
| Torgerson, DJ | 2 |
| Al-Samkari, H | 1 |
| Parot-Schinkel, E | 1 |
| Roquilly, A | 1 |
| Desebbe, O | 1 |
| Garrigue, D | 1 |
| Mounet, B | 1 |
| Hamard, F | 1 |
| Pempe, C | 1 |
| Werdehausen, R | 1 |
| Pieroh, P | 1 |
| Federbusch, M | 1 |
| Petros, S | 1 |
| Henschler, R | 1 |
| Roth, A | 1 |
| Pfrepper, C | 1 |
| Cybulska, P | 1 |
| Goss, C | 1 |
| Tew, WP | 1 |
| Parameswaran, R | 1 |
| Sonoda, Y | 1 |
| Alexander, DP | 1 |
| Frew, N | 1 |
| Klement, MR | 2 |
| Peres-Da-Silva, A | 1 |
| Nickel, BT | 1 |
| Green, CL | 4 |
| Wellman, SS | 2 |
| Attarian, DE | 1 |
| Bolognesi, MP | 3 |
| Seyler, TM | 4 |
| Rohrich, RJ | 1 |
| Cho, MJ | 1 |
| Olaussen, A | 1 |
| Bade-Boon, J | 1 |
| Fitzgerald, MC | 1 |
| Mitra, B | 1 |
| Zhang, S | 1 |
| Huang, Q | 1 |
| Xu, B | 1 |
| Ma, J | 1 |
| Cao, G | 1 |
| Pei, F | 1 |
| Polanco-García, M | 1 |
| Capielo, AM | 1 |
| Miret, X | 1 |
| Chamero, A | 1 |
| Sainz, J | 1 |
| Revilla, E | 1 |
| Guinjoan, A | 1 |
| Arranz, T | 1 |
| Kildow, BJ | 2 |
| Howell, EP | 2 |
| Karas, V | 2 |
| Baumgartner, WT | 1 |
| Cunningham, DJ | 2 |
| Pavenski, K | 1 |
| Ward, SE | 1 |
| Hare, GMT | 1 |
| Freedman, J | 1 |
| Pulendrarajah, R | 1 |
| Pirani, RA | 1 |
| Sheppard, N | 1 |
| Vance, C | 1 |
| White, A | 1 |
| Lo, N | 1 |
| Waddell, JP | 1 |
| Ho, A | 1 |
| Schemitsch, EH | 1 |
| Kataoka, M | 1 |
| Bogoch, ER | 1 |
| Saini, K | 1 |
| David Mazer, C | 1 |
| Baker, JE | 1 |
| Halawi, MJ | 1 |
| Plourde, JM | 1 |
| Cote, MP | 1 |
| Ker, K | 2 |
| Fawole, B | 1 |
| Bates, I | 1 |
| Wolfson, TS | 1 |
| Novikov, D | 1 |
| Chen, KK | 1 |
| Kim, KY | 1 |
| Anoushiravani, AA | 1 |
| Deshmukh, AJ | 1 |
| Lajam, CM | 1 |
| Lemoine, A | 1 |
| Lambaudie, E | 1 |
| Bonnet, F | 1 |
| Leblanc, E | 1 |
| Alfonsi, P | 1 |
| Sun, Q | 1 |
| Li, J | 1 |
| Chen, J | 1 |
| Zheng, C | 1 |
| Liu, C | 1 |
| Jia, Y | 1 |
| Ryan, SP | 2 |
| Blizzard, DJ | 1 |
| Wu, XD | 1 |
| Xiao, PC | 1 |
| Zhu, ZL | 1 |
| Liu, JC | 1 |
| Li, YJ | 1 |
| Huang, W | 1 |
| Abeysiri, S | 1 |
| Chau, M | 1 |
| Highton, D | 1 |
| Richards, T | 1 |
| Theusinger, OM | 1 |
| Stein, P | 1 |
| Spahn, DR | 1 |
| Bagsby, DT | 1 |
| Hur, J | 1 |
| Schwameis, M | 1 |
| Thaler, J | 1 |
| Schober, A | 1 |
| Schörgenhofer, C | 1 |
| Kulinna-Cosentini, C | 1 |
| Laggner, A | 1 |
| Röggla, M | 1 |
| Jilma, B | 1 |
| Albinarrate, A | 1 |
| López-Picado, A | 1 |
| Oiartzabal, I | 1 |
| López-Ariznabarreta, C | 1 |
| Molano, J | 1 |
| Barrachina, B | 1 |
| Muñoz Gómez, M | 1 |
| Bisbe Vives, E | 1 |
| Basora Macaya, M | 1 |
| García Erce, JA | 1 |
| Gómez Luque, A | 1 |
| Leal-Noval, SR | 1 |
| Colomina, MJ | 1 |
| Comin Colet, J | 1 |
| Contreras Barbeta, E | 1 |
| Cuenca Espiérrez, J | 1 |
| Garcia de Lorenzo Y Mateos, A | 1 |
| Gomollón García, F | 1 |
| Izuel Ramí, M | 1 |
| Moral García, MV | 1 |
| Montoro Ronsano, JB | 1 |
| Páramo Fernández, JA | 1 |
| Pereira Saavedra, A | 1 |
| Quintana Diaz, M | 1 |
| Remacha Sevilla, Á | 1 |
| Salinas Argente, R | 1 |
| Sánchez Pérez, C | 1 |
| Tirado Anglés, G | 1 |
| Torrabadella de Reinoso, P | 1 |
| Holt, JB | 1 |
| Miller, BJ | 1 |
| Callaghan, JJ | 1 |
| Clark, CR | 1 |
| Willenborg, MD | 1 |
| Noiseux, NO | 1 |
| Sizer, SC | 1 |
| Cherian, JJ | 1 |
| Elmallah, RD | 1 |
| Pierce, TP | 1 |
| Beaver, WB | 1 |
| Mont, MA | 1 |
| Phan, DL | 1 |
| Ani, F | 1 |
| Schwarzkopf, R | 1 |
| Khan, N | 1 |
| Troelsen, A | 1 |
| Husted, H | 1 |
| Chaudet, A | 1 |
| Chassier, C | 1 |
| Bizot, P | 1 |
| Kopanidis, P | 1 |
| Hardidge, A | 1 |
| McNicol, L | 1 |
| Tay, S | 1 |
| McCall, P | 1 |
| Weinberg, L | 1 |
| Kiseli, M | 1 |
| Kayikcioglu, F | 1 |
| Evliyaoglu, O | 1 |
| Haberal, A | 1 |
| Park, KJ | 1 |
| Couch, CG | 1 |
| Edwards, PK | 1 |
| Siegel, ER | 1 |
| Mears, SC | 1 |
| Barnes, CL | 1 |
| Suh, DW | 1 |
| Han, SB | 1 |
| Park, JH | 1 |
| Cheong, K | 1 |
| Kyung, BS | 1 |
| Kasparek, MF | 1 |
| Faschingbauer, M | 1 |
| Waldstein, W | 1 |
| Boettner, CS | 1 |
| Boettner, F | 1 |
| Styron, JF | 1 |
| Klika, AK | 1 |
| Szubski, CR | 1 |
| Tolich, D | 1 |
| Barsoum, WK | 1 |
| Higuera, CA | 1 |
| Rosencher, N | 1 |
| Bellamy, L | 1 |
| Chabbouh, T | 1 |
| Arnaout, L | 1 |
| Ozier, Y | 1 |
| Ahn, SW | 1 |
| Shim, JK | 1 |
| Youn, YN | 1 |
| Song, JW | 1 |
| Yang, SY | 1 |
| Chung, SC | 1 |
| Kwak, YL | 1 |
| Sorensen, B | 1 |
| Fries, D | 1 |
| Watts, CD | 1 |
| Pagnano, MW | 1 |
| Murphy, DP | 1 |
| O'Donnell, T | 1 |
| McDonnell, J | 1 |
| McElwain, JP | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Tranexamic Acid for the Prevention of Postpartum Bleeding in Women With Anaemia: an International, Randomised, Double-blind, Placebo Controlled Trial.[NCT03475342] | Phase 3 | 15,000 participants (Anticipated) | Interventional | 2019-08-24 | Recruiting | ||
| Serum Hepcidin and Iron Status Parameters in Pregnant Women and the Association With Adverse Maternal and Fetal Outcome[NCT03792464] | 188 participants (Actual) | Observational | 2019-04-30 | Completed | |||
| Iron Prehabilitation and Perioperative Infectious Diseases of Endometrial Cancer Patients[NCT06049693] | Phase 4 | 100 participants (Anticipated) | Interventional | 2023-01-01 | Enrolling by invitation | ||
| HiFIT Study: Interest of Intravenous Iron and Tranexamic Acid to Reduce Transfusion in Hip Fracture Patients[NCT02972294] | Phase 3 | 419 participants (Actual) | Interventional | 2017-03-31 | Terminated (stopped due to 1year inclusion hold due to PV new fact (Monofer hold for risk revaluation) DSMB Interim analysis : 1treatment with important transfusion risk reduction/inclusions issues (COVID)/sites change of practice if study continue=>stop inclusions) | ||
| The Effect of Local Tranexamic Acid on Post-operative Edema and Ecchymosis in Eyelid Surgery[NCT04951128] | Phase 4 | 50 participants (Anticipated) | Interventional | 2021-08-01 | Not yet recruiting | ||
| Use of TRanEXamic Acid in Reduction Mammoplasty (TREX-ARM): a Double-blinded Randomized Controlled Trial[NCT04947514] | Phase 4 | 98 participants (Actual) | Interventional | 2021-10-29 | Completed | ||
| Role of Tranexamic Acid (TXA) in the Reduction of Post-operative Hematoma and Seroma in Patients Undergoing Panniculectomy or Abdominoplasty, a Pilot Study.[NCT04902950] | Phase 4 | 9 participants (Actual) | Interventional | 2020-08-17 | Terminated (stopped due to Logistics) | ||
| Use of Tranexamic Acid in Liposculpture: A Double-blind, Multicenter, Randomized Trial[NCT04430777] | Phase 2/Phase 3 | 141 participants (Actual) | Interventional | 2019-01-17 | Completed | ||
| Extended Postoperative Tranexamic Acid Use in Primary Total Knee Arthroplasty: A Prospective, Randomized Controlled Trial[NCT05099276] | Phase 4 | 46 participants (Actual) | Interventional | 2021-12-07 | Active, not recruiting | ||
| "Change in Transfusion Rates of Patients Undergoing Elective Total Hip Replacement Before/After the Implementation of a Peri-operative Patient Blood Management Program: a Retrospective Observational Study."[NCT04398238] | 400 participants (Actual) | Observational | 2021-08-01 | Completed | |||
| Prospective Randomized Study Comparing Topical Versus Intravenous Tranexamic Acid in Anterior Total Hip Arthroplasty[NCT03359525] | Phase 4 | 114 participants (Anticipated) | Interventional | 2017-07-01 | Recruiting | ||
| Estimation of Coagulation Factor XIII Activity Based on the Initial Plasma Fibrinogen Level in Trauma[NCT03634215] | 357 participants (Actual) | Observational | 2018-09-01 | Completed | |||
| Efficacy and Safety of Erythropoietin And/Or Intravenous Iron Sucrose For Treatment of Anemia In Hip and Knee Arthroplasty: A Single-center Retrospective Study[NCT03917394] | 780 participants (Anticipated) | Observational | 2019-04-24 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The number of breasts with clinically significant hematoma (collection of blood under the skin) requiring either conservative management or operative washout was determined. (NCT04947514)
Timeframe: Up to 30 days
| Intervention | breasts (Number) |
|---|---|
| Treatment Side (Right or Left) | 2 |
| Placebo Side (Right or Left) | 1 |
The number of participants requiring blood transfusion was based on the postoperative decline in hematocrit level (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
Incidence of clinically significant deep vein thrombosis or pulmonary embolism detected on imaging (ultrasound or CT scan) (NCT04947514)
Timeframe: Up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Treatment Side (Right or Left) | 0 |
| Placebo Side (Right or Left) | 0 |
The number of days that the post surgical drains remain in place after the surgery. When less than 30 cc per drain in a 24-hour period, the participants are to call and schedule drain removal. (NCT04902950)
Timeframe: Up to 56 days post operatively.
| Intervention | Days (Mean) |
|---|---|
| Group 1 | 16 |
| Group 2 | 22 |
Return to the operating room for evacuation post surgical operative hematoma or seroma assessed by clinical evaluation to include palpation for ballotable fluid collection and assessment of skin for a shiny/tight appearance suggestive of an underlying fluid collection. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Group 1 | 0 |
| Group 2 | 0 |
Patients will be monitored clinically at each post-operative visit for signs of post-operative hematoma or seroma. Each patient will be evaluated one week, three weeks, and eight weeks following their procedure to assess overall wound healing. (NCT04902950)
Timeframe: Up to 8 weeks postoperatively
| Intervention | Participants (Count of Participants) |
|---|---|
| Group 1 | 0 |
| Group 2 | 1 |
17 reviews available for tranexamic acid and Anemia
| Article | Year |
|---|---|
Patient blood management and patient safety.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Humans; Patient Safety; Tranexamic Acid | 2022 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.
Topics: Aged; Anemia; Emergence Delirium; Erythrocyte Transfusion; Hemorrhage; Hip Fractures; Humans; Iron; | 2023 |
Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care.
Topics: Anemia; Angiogenesis Inhibitors; Anticoagulants; Antifibrinolytic Agents; Clinical Trials as Topic; | 2021 |
Indications for and complications of transfusion and the management of gynecologic malignancies.
Topics: Acute Lung Injury; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Erythrocyte Transfusion; F | 2017 |
Preoperative optimisation of anaemia for primary total hip arthroplasty: a systematic review.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Erythropoietin; | 2017 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
The Role of Tranexamic Acid in Plastic Surgery: Review and Technical Considerations.
Topics: Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Cardiac Surgical Procedure | 2018 |
[Perioperative care of epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF a
Topics: Analgesia, Patient-Controlled; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Carcinoma, Ova | 2019 |
Comparison of intravenous, topical or combined routes of tranexamic acid administration in patients undergoing total knee and hip arthroplasty: a meta-analysis of randomised controlled trials.
Topics: Administration, Intravenous; Administration, Topical; Anemia; Antifibrinolytic Agents; Arthroplasty, | 2019 |
Management of the patient presenting with anaemia in the preoperative setting.
Topics: Anemia; Blood Loss, Surgical; Erythrocyte Transfusion; Humans; Operative Blood Salvage; Preoperative | 2019 |
Applying 'Patient Blood Management' in the trauma center.
Topics: Anemia; Blood Coagulation Disorders; Blood Coagulation Factors; Blood Transfusion; Deamino Arginine | 2014 |
Predicting Blood Loss in Total Knee and Hip Arthroplasty.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2015 |
Prevention of post-operative anaemia in hip and knee arthroplasty--a systematic review.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, K | 2015 |
[Blood conservation approaches in orthopedic surgery].
Topics: Anemia; Aprotinin; Blood Loss, Surgical; Blood Transfusion; Blood Transfusion, Autologous; Drug Admi | 2008 |
Emerging treatment strategies for trauma-induced coagulopathy.
Topics: Acidosis; Anemia; Antifibrinolytic Agents; Bandages; Blood Coagulation Disorders; Blood Coagulation | 2012 |
Minimising blood loss and transfusion in contemporary hip and knee arthroplasty.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2012 |
Treatment of anaemia in the polytrauma Jehovah's Witness.
Topics: Anemia; Antifibrinolytic Agents; Blood Substitutes; Blood Transfusion; Fluorocarbons; Hemodilution; | 2003 |
8 trials available for tranexamic acid and Anemia
33 other studies available for tranexamic acid and Anemia
| Article | Year |
|---|---|
Postpartum haemorrhage in anaemic women: assessing outcome measures for clinical trials.
Topics: Anemia; Delivery, Obstetric; Female; Humans; Outcome Assessment, Health Care; Postpartum Hemorrhage; | 2022 |
Predicting Postoperative Anemia and Blood Transfusion Following Total Knee Arthroplasty.
Topics: Aged; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood | 2023 |
The Association of Intravenous Iron Administered the Day before Total Knee Arthroplasty with Postoperative Anemia and Functional Recovery.
Topics: Anemia; Anemia, Iron-Deficiency; Arthroplasty, Replacement, Knee; Ferritins; Hemoglobins; Humans; Re | 2023 |
Risk factors for blood transfusion and postoperative anaemia following total knee arthroplasty.
Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transfusion; Female; Hemo | 2023 |
An observational study of an adjusted patient blood management protocol intended to lower rates of transfusion following total knee arthroplasty in patients with preoperative anemia.
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Blood Transf | 2023 |
The value of tranexamic acid for patients with preoperative anemia in primary total knee arthroplasty.
Topics: Aged; Anemia; Arthroplasty, Replacement, Knee; Blood Loss, Surgical; Chi-Square Distribution; Female | 2019 |
Peri-operative administration of tranexamic acid in lower limb arthroplasty: a multicentre, prospective cohort study.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement; Arthroplasty, R | 2020 |
Effectiveness of pre-operative anaemia screening and increased Tranexamic acid dose policies on outcomes following unilateral primary, elective total hip or knee replacement: a statistical analysis plan for an interrupted time series and regression discon
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2020 |
Effectiveness of pre-operative anaemia screening and increased Tranexamic acid dose policies on outcomes following unilateral primary, elective total hip or knee replacement: a statistical analysis plan for an interrupted time series and regression discon
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2020 |
Effectiveness of pre-operative anaemia screening and increased Tranexamic acid dose policies on outcomes following unilateral primary, elective total hip or knee replacement: a statistical analysis plan for an interrupted time series and regression discon
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2020 |
Effectiveness of pre-operative anaemia screening and increased Tranexamic acid dose policies on outcomes following unilateral primary, elective total hip or knee replacement: a statistical analysis plan for an interrupted time series and regression discon
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bl | 2020 |
Predictors for blood loss and transfusion frequency to guide blood saving programs in primary knee- and hip-arthroplasty.
Topics: Aged; Anemia; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bioma | 2021 |
What Should Define Preoperative Anemia in Primary THA?
Topics: Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Biomarkers; Blood Loss, Surgical; | 2017 |
Management of injured patients who were Jehovah's Witnesses, where blood transfusion may not be an option: a retrospective review.
Topics: Anemia; Australia; Blood Transfusion; Erythropoietin; Female; Hemorrhage; Humans; Jehovah's Witnesse | 2018 |
Effectiveness and safety of an optimized blood management program in total hip and knee arthroplasty: A large, single-center, retrospective study.
Topics: Administration, Intravenous; Administration, Topical; Adult; Aged; Anemia; Antifibrinolytic Agents; | 2018 |
Effectiveness of a patient blood management protocol on reduction of allogeneic red blood cell transfusions in orthopedic surgery.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplas | 2019 |
When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients?
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blo | 2018 |
A rationale for universal tranexamic acid in major joint arthroplasty: overall efficacy and impact of risk factors for transfusion.
Topics: Anemia; Antifibrinolytic Agents; Blood Transfusion; Body Mass Index; Erythrocytes; Female; Humans; L | 2019 |
Routine Postoperative Laboratory Tests Are Not Necessary After Primary Total Hip Arthroplasty.
Topics: Acute Kidney Injury; Aged; Anemia; Arthroplasty, Replacement, Hip; Blood Chemical Analysis; Blood Lo | 2019 |
Total Knee Arthroplasty Is Safe in Jehovah's Witness Patients-A 12-Year Perspective.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Los | 2020 |
Preoperative Hemoglobin Predicts Postoperative Transfusion Despite Antifibrinolytics During Total Knee Arthroplasty.
Topics: Age Factors; Aged; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Transfusi | 2019 |
Clinical Impact of Routine Complete Blood Counts Following Total Knee Arthroplasty.
Topics: Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Knee; Blood Cel | 2019 |
The necessity of routine postoperative laboratory tests in enhanced recovery after surgery for primary hip and knee arthroplasty: A retrospective cohort study protocol.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, K | 2019 |
Effect of intra-articular injection of tranexamic acid on postoperative hemoglobin in total hip arthroplasty.
Topics: Aged; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Transfusion; Female; He | 2014 |
Tranexamic acid and fibrinogen restore clotting in vitro and in vivo in cardiac thrombus associated hyperfibrinolysis with overt bleedings.
Topics: Adenocarcinoma; Aged; Anemia; Antifibrinolytic Agents; Antineoplastic Combined Chemotherapy Protocol | 2014 |
Assessment of the introduction of a blood management program in orthopaedic surgery.
Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Biomarkers; Blood Ban | 2015 |
Forum for debate: Safety of allogeneic blood transfusion alternatives in the surgical/critically ill patient.
Topics: Anemia; Antifibrinolytic Agents; Aprotinin; Blood Coagulation Factors; Blood Transfusion; Clinical T | 2015 |
Minimizing Blood Transfusion in Total Hip and Knee Arthroplasty Through a Multimodal Approach.
Topics: Aged; Aged, 80 and over; Algorithms; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip | 2016 |
Cost Analysis of Tranexamic Acid in Anemic Total Joint Arthroplasty Patients.
Topics: Aged; Anemia; Antifibrinolytic Agents; Arthroplasty; Blood Loss, Surgical; Blood Transfusion; Cost-B | 2016 |
Implementing a blood management protocol during the entire perioperative period allows a reduction in transfusion rate in major orthopedic surgery: a before-after study.
Topics: Adult; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; C | 2016 |
Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replaceme | 2016 |
Tranexamic Acid Reduces Blood Transfusions in Revision Total Hip Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blo | 2016 |
Intravenous iron supplementation with intra-articular administration of tranexamic acid reduces the rate of allogeneic transfusions after simultaneous bilateral total knee arthroplasty.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplasty, | 2017 |
Topical Tranexamic Acid is Equivalent to Targeted Preoperative Autologous Blood Donation in Total Hip Arthroplasty.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anemia; Antifibrinolytic Agents; Arthroplas | 2017 |
Relative efficacy of tranexamic acid and preoperative anemia treatment for reducing transfusions in total joint arthroplasty.
Topics: Aged; Anemia; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Transfusion; Fe | 2017 |
Tranexamic acid for postpartum bleeding.
Topics: Anemia; Antifibrinolytic Agents; Cesarean Section; Female; Humans; Postpartum Hemorrhage; Pregnancy; | 2011 |